U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07440173) titled 'Phenol and Botulinum Toxin vs Botulinum Toxin Alone for Post-Stroke Upper-Limb Spasticity' on Feb. 20.
Brief Summary: This study aims to evaluate the efficacy of a combined treatment approach for post-stroke upper limb spasticity using phenol neurolysis and botulinum toxin (BoNT). Spasticity is a common post-stroke complication that leads to muscle stiffness and significantly hinders functional recovery. While botulinum toxin is the standard treatment, its high cost often limits its application, particularly for large proximal muscles.
The researchers will compare two treatment strategies in 60 adult stroke survivors:
Group A (Com...